Annotated Medicine and Device Lists

Human normal immunoglobulin

Intramuscular administration 16% protein solution Intramuscular administration 10% protein solution in 2-mL vial Intravenous administration 5% protein solution Intravenous administration 10% protein solution Subcutaneous administration 15% protein solution Subcutaneous administration 16% protein solution

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	11.2.1 Human immunoglobulins	Others observations: Indicated for primary immune deficiency.
PAHO Strategic Fund Medicine List	4.1. Plasma fractions for specific use	Others observations: Indicated for primary immune deficiency.

This medicine is present in:

List	Section	Observation
Cuba	19.2 Sueros e inmunoglobulinas	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	11.2.1 Human immunoglobulins	Others observations: Indicated for primary immune deficiency and Kawasaki disease.
PAHO Strategic Fund Medicine List	4.1. Plasma fractions for specific use	Others observations: Indicated for primary immune deficiency and Kawasaki disease.
Bolivia	LINAME 2011 - 2013	No observations
Cuba	19.2 Sueros e inmunoglobulinas	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	11.2.1 Human immunoglobulins	Others observations: Indicated for primary immune deficiency and Kawasaki disease.
PAHO Strategic Fund Medicine List	4.1. Plasma fractions for specific use	Others observations: Indicated for primary immune deficiency and Kawasaki disease.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	11.2.1 Human immunoglobulins	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
WHO Model List of Essential Medicines (2021)	11.2.1 Human immunoglobulins	No observations

Information Resources: Human normal immunoglobulin

No information available